Our goal

Successfully developing any gene therapy is incredibly challenging. There are countless pitfalls and technical bridges to cross throughout the development cycle and many gene therapy products fall along the wayside as a result.

What’s really needed is a concerted effort from both the academic and industrial sectors to come together and create an ecosystem that catalyses the gene therapy development process and increases the chance of successfully bringing them to the clinic.

Our goal is to aid the development of such an ecosystem within Flanders and the wider EU region. By collaborating with academic and industrial partners on a variety of projects, we are looking to focus on the key areas required to streamline the gene therapy development cycle, as well as developing our own enabling technologies and training courses to help newcomers to the field.

Be it novel vector or capsid designs, production plasmid designs, up- or downstream bioprocessing practices or analytical methods, our team is dedicated to collaboratively studying the fundamental aspects of AAV-based gene therapies. We also support promising new development programmes on their way from fundamental research to authorised medicines.